What price did Edith Aviles pay per Scotts Miracle-Gro (SMG) share?

The reported acquisition price per share was $0. The 336 common shares came from the vesting and conversion of restricted stock units and related dividend equivalent rights, which are part of equity compensation, rather than shares bought for cash in the open market.

Scotts Miracle-Gro (NYSE: SMG) director gets 336 new shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Scotts Miracle-Gro director Edith Aviles reported a share acquisition tied to equity awards. On February 3, 2026, 336 restricted stock units converted into 336 common shares at a price of $0 per share, reflecting a vesting event rather than an open-market purchase.

The filing also shows a related transaction in 336 dividend equivalent rights, which are linked to the same underlying common shares. After these transactions, Aviles directly holds 14,304 common shares and 447 dividend equivalent rights in Scotts Miracle-Gro.

Insider Trade Summary

336 shares exercised/converted

Mixed 2 txns

Insider Aviles Edith

Role Director

Type	Security	Shares	Price	Value
Exercise	Dividend Equivalent Rights	336	$0.00	--
Exercise	Common Shares	336	$0.00	--

Holdings After Transaction: Dividend Equivalent Rights — 447 shares (Direct); Common Shares — 14,304 shares (Direct)

Footnotes (1)

Restricted stock units convert into common shares of the Issuer on a one-for-one basis. On February 3, 2023, the reporting person was granted 2,553 restricted stock units, with accruing dividend equivalent rights, vesting on February 3, 2024.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/05/2026 - 11:55 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aviles Edith

(Last)

(First)

(Middle)

C/O THE SCOTTS MIRACLE-GRO COMPANY

14111 SCOTTSLAWN ROAD

(Street)

MARYSVILLE

43041

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
SCOTTS MIRACLE-GRO CO [ SMG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	02/03/2026		M		336	A	⁽¹⁾	14,304	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Dividend Equivalent Rights	⁽¹⁾	02/03/2026		M			336	⁽²⁾	⁽²⁾	Common Shares	336	$0	447	D

Explanation of Responses:

1. Restricted stock units convert into common shares of the Issuer on a one-for-one basis.

2. On February 3, 2023, the reporting person was granted 2,553 restricted stock units, with accruing dividend equivalent rights, vesting on February 3, 2024.

Remarks:

	/s/ Kathy L. Uttley as attorney-in-fact for Edith Aviles	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Scotts Miracle-Gro (SMG) director Edith Aviles report in this Form 4?

Edith Aviles reported the conversion of equity awards into common shares of Scotts Miracle-Gro. A block of 336 restricted stock units converted into 336 common shares, along with related dividend equivalent rights, reflecting a compensation-related vesting event rather than a market trade.

How many Scotts Miracle-Gro (SMG) shares did Edith Aviles acquire?

Edith Aviles acquired 336 common shares of Scotts Miracle-Gro through the conversion of previously granted restricted stock units. These units convert into common shares on a one-for-one basis, increasing her directly held common share position without an open-market purchase.

What are dividend equivalent rights in Edith Aviles’s Scotts Miracle-Gro (SMG) filing?

Dividend equivalent rights are derivative rights that track dividends on underlying shares. In this filing, 336 dividend equivalent rights were tied to 336 common shares from restricted stock units, and 447 such rights remain directly held after the reported transactions.

How many Scotts Miracle-Gro (SMG) shares does Edith Aviles hold after this transaction?

After the reported Form 4 transactions, Edith Aviles directly holds 14,304 common shares of Scotts Miracle-Gro. She also directly holds 447 dividend equivalent rights, which are linked to underlying common shares as part of her prior equity awards.

What do the restricted stock unit details in the Scotts Miracle-Gro (SMG) Form 4 show?

A footnote explains that restricted stock units convert into common shares on a one-for-one basis. Another footnote notes a prior grant of 2,553 restricted stock units with accruing dividend equivalent rights, which were scheduled to vest on February 3, 2024.